Cupric Chloride Injection, Solution
Product Images NDC 84897-013

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cupric Chloride (NDC 84897-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Renova Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

This text appears to be a description of Cupric Chloride Injection, USP, with a concentration of 4mg/10mL. It provides instructions for proper usage, including dilution before intravenous use, storage guidelines, and details about the contents of the injection. The product is meant for single-dose vials and should be used within 24 hours after preparation. The text also mentions the manufacturer Renova Pharmaceuticals LLC and their contact information.*

FDA Label Image

Containerlabel (Containerlabel)

This text appears to be a medication label for an injectable solution containing Cupric chloride and Sodium chloride. It provides details on the components present in each milliliter, such as Cupric chloride 1.07 mg, Sodium chloride, and Cupric Chloride 9 mg. The solution has an osmolality of 0.327 mOsmol/mL and a pH of 2.0. The recommended dosage is indicated on the insert. It is advised to use the solution only after dilution and to discard any unused portion. This medication is distributed by Renova Pharmaceuticals LLC and should contain no more than 15,000 micrograms per liter of aluminum. The medication is in a 10 mL single-dose vial.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.